Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Probiotics  COVID-19 treatment studies for Probiotics  C19 studies: Probiotics  Probiotics   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Probiotics: A potential immunomodulator in COVID-19 infection management
Singh et al., Nutrition Research, doi:10.1016/j.nutres.2020.12.014 (Review)
Singh et al., Probiotics: A potential immunomodulator in COVID-19 infection management, Nutrition Research, doi:10.1016/j.nutres.2020.12.014 (Review)
Feb 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Review of studies supporting the use of probiotics for respiratory infections and identification of microbial strains potentially beneficial for COVID-19.
Singh et al., 13 Feb 2021, peer-reviewed, 2 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperProbioticsAll
Abstract: Nutrition Research 87 (2021) 1–12 Available online at www.sciencedirect.com journal homepage: www.elsevier.com/locate/NTR Review Article Probiotics: A potential immunomodulator in COVID-19 infection management Kuljit Singh a,#, Alka Rao a,b,∗ a CSIR-Institute b Academy of Microbial Technology, Sector 39A, Chandigarh 160036 India of Scientific and Innovation Research (AcSIR), Ghaziabad, Uttar Pradesh 201002 India a r t i c l e i n f o a b s t r a c t Article history: COVID-19 caused by SARS-CoV-2 is an ongoing global pandemic. SARS-CoV-2 affects the Received 1 June 2020 human respiratory tract’s epithelial cells, leading to a proinflammatory cytokine storm and Revised 2 December 2020 chronic lung inflammation. With numerous patients dying daily, a vaccine and specific an- Accepted 15 December 2020 tiviral drug regimens are being explored. Probiotics are live microorganisms with proven beneficial effects on human health. While probiotics as nutritional supplements are long practiced in different cuisines across various countries, the emerging scientific evidence Keywords: supports the antiviral and general immune-strengthening health effects of the probiotics. COVID-19 Here, we present an overview of the experimental studies published in the last 10 years Influenza virus that provide a scientific basis for unexplored probiotics as a preventive approach to respira- Lactobacillus tory viral infections. Based on collated insights from these experimental data, we identify Probiotics promising microbial strains that may serve as lead prophylactic and immune-boosting pro- Respiratory viral infection biotics in COVID-19 management. SARS-CoV-2
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit